- 专利标题: GUANIDINOBENZOIC ACID ESTER COMPOUND
-
申请号: EP14763790.4申请日: 2014-03-13
-
公开(公告)号: EP2975023B1公开(公告)日: 2018-05-30
- 发明人: FUJIYASU, Jiro , ASANO, Toru , YAMAKI, Susumu , KANEKO, Osamu , KOIKE, Yuka , IMAIZUMI, Tomoyoshi , URANO, Yasuharu , SATOU, Tomohki , SASAMURA, Satoshi
- 申请人: Takeda Pharmaceutical Company Limited
- 申请人地址: 1-1, Doshomachi 4-chome, Chuo-ku, Osaka-shi, Osaka 541-0045, JP
- 专利权人: Takeda Pharmaceutical Company Limited
- 当前专利权人: Takeda Pharmaceutical Company Limited
- 当前专利权人地址: 1-1, Doshomachi 4-chome, Chuo-ku, Osaka-shi, Osaka 541-0045, JP
- 代理机构: Jones, Nicholas Andrew
- 优先权: JP2013050011 20130313
- 国际公布: WO2014142219 20140918
- 主分类号: C07D333/40
- IPC分类号: C07D333/40 ; C07C279/18 ; C07D307/81 ; C07D333/68 ; C07D333/70 ; C07D217/26 ; C07D333/24 ; A61K31/381 ; A61K31/24 ; A61K31/343 ; A61K31/472 ; A61P13/12
摘要:
[Problem] To provide a compound which is useful as an agent for preventing and/or treating kidney diseases. [Means for Solution] The present inventors have studied compounds having a trypsin inhibitory activity, and have confirmed that a guanidinobenzoic acid ester compound has a trypsin inhibitory activity, thereby completing the present invention. The guanidinobenzoic acid ester compound of the present invention can be used as an agent for preventing and/or treating kidney diseases (for example, chronic kidney disease, acute glomerulonephritis, acute kidney injury, and the like) as an agent which will substitute low-protein diet therapy, and/or as an agent for preventing and/or treating trypsin-related diseases (for example, chronic pancreatitis, gastroesophageal reflux disease, hepatic encephalopathy, influenza, and the like).
公开/授权文献
- EP2975023A1 GUANIDINOBENZOIC ACID ESTER COMPOUND 公开/授权日:2016-01-20
信息查询